article · 2012
Effect of treatment with 5‐α reductase inhibitors on progression in monitored men with favourable‐risk prostate cancer
Treatment with 5-ARIs did not significantly alter the outcome of biopsy reclassification by grade in men with very low-risk prostate cancer.
38 citationsDOI: https://doi.org/10.1111/j.1464-410x.2011.10875.xOpen access